![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 295/13 | (2006.01) |
C07C 211/22 | (2006.01) | ||
C07C 233/36 | (2006.01) | ||
C07C 233/38 | (2006.01) | ||
C07C 235/74 | (2006.01) | ||
A61K 47/18 | (2017.01) |
(11) | Number of the document | 3313829 |
(13) | Kind of document | T |
(96) | European patent application number | 16738338.9 |
Date of filing the European patent application | 2016-06-29 | |
(97) | Date of publication of the European application | 2018-05-02 |
(45) | Date of publication and mention of the grant of the patent | 2024-04-10 |
(46) | Date of publication of the claims translation | 2024-08-12 |
(86) | Number | PCT/US2016/039999 |
Date | 2016-06-29 |
(87) | Number | WO 2017/004143 |
Date | 2017-01-05 |
(30) | Number | Date | Country code |
201562186210 P | 2015-06-29 | US |
(72) |
DU, Xinyao , CA
ANSELL, Steven, M. , CA
|
(73) |
Acuitas Therapeutics Inc. ,
6190 Agronomy Road
Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5,
CA
|
(74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Lipidai ir lipidų nanodalelių sudėtys, skirtos nukleorūgščių tiekimui |
LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS |
Payment date | Validity (years) | Amount | |
2025-06-02 | 10 | 231.00 EUR |
2026-06-29 |